· Genprex, Inc. View the latest Genprex Inc. Based on the current price of €2. Investors can use this forecasting interface to forecast Genprex historical stock prices and determine the direction of Genprex&39;s future trends based on various well-known forecasting models. Genprex stock forecast, GNPX price prediction: genprex stock forecast Buy or sell Genprex, Inc shares? It considers technical and. Get the latest GENPREX INC GNPX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.
It develops the Oncoprex immunogene therapy which targets the non-small cell lung cancer and other solid tumors. Get full conversations at Yahoo Finance. There are mixed signals in the stock today. (GNPX) stock price, news, historical charts, analyst ratings and financial information from WSJ. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. earnings per share revisions and analysts forecast | Nasdaq: GNPX | Nasdaq.
Get the latest information on Genprex stock (NASDAQ: GNPX), including a real-time stock price quote, news, financials, charts and more. Genprex Stock Forecast, Price & News announce their quarterly, annual earnings. Do Wall Street analysts recommend investors buy shares of Genprex? It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. During that period the price should oscillate between -7. Genprex&39;s stock was trading at .
Genprex has generated (. · View today&39;s stock price, news and analysis for Genprex Inc. · The Relative Strength Index (RSI, 14) currently prints 48. Genprex (GNPX) stock price prediction is 2. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. It was the latest piece of big news for a firm that has. (GNPX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.
An Overall Rank of 77 means that our comprehensive methodology rates Genprex Inc above 77% of stocks. Find the latest Genprex, Inc. The 3-month trading volume is 1.
· Genprex, Inc. GNPX Stock Predictions, Articles, and Genprex Inc News. &39;s stock price was made on the Sept. Since then, GNPX shares have increased by 38. 5, when the stock price was at 0. What this means: Genprex Inc (GNPX) gets an Overall Rank of 59, which is an above average rank under InvestorsObserver&39;s stock ranking system.
53%) Wed,, 4:00PM EST If we genprex stock forecast look at the company’s 10-day average daily trading genprex stock forecast volume, we find that it stood at 737. 00, with a high forecast of . had a big week on Wall Street after sealing a deal with MD Anderson Cancer Center to genprex advance research and development efforts. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. Stock Price: GNPX (NasdaqGS) .
Currently there is a rather positive sentiment for Genprex Inc with 3 Buy predictions and 1 Sell predictions. However, solely looking at the historical price movement is usually misleading. See Genprex, Inc. 98 the target price genprex stock forecast of €7. Signals & Forecast The Genprex Inc. 725 USD for October 15, Friday.
12) EPS for the quarter, beating analysts&39; consensus estimates of (. Common Stock (GNPX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. See full list on gov. We are developing gene therapies for patients with cancer and diabetes to bring new therapies to large patient populations. for immunogene therapy Oncoprex, comb. The average price target is . Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. With a 5-year investment, the revenue is expected to be around +355.
· GNPX stock forecast Our latest prediction for Genprex, Inc. is a clinical stage gene therapy company, which engages in the development of novel proprietary technology platform for the treatment of cancer. 92% above the 52-week low of . · Nano cap Genprex (GNPX +308. GNPX: Get the latest Genprex stock price and detailed information including GNPX news, historical charts and realtime prices. 57 Million shares.
is estimated to report earnings on. Barron&39;s also provides information on historical stock ratings, target prices, company earnings, market valuation and more. 67 Million shares traded. Listen to the conference call and remind yourself by. Who this matters to: Overall Ranking is a comprehensive evaluation. 67, while 7-day volatility ratio is 5. 60-Month Beta: Coefficient that measures the genprex stock forecast volatility of a stock&39;s returns relative to the market genprex stock forecast (S&P 500).
The reported (. Find the latest Earnings Report Date for Genprex, Inc. Our lead product candidate, REQORSA™ immunogene therapy, is designed to be administered in combination with other therapies, including targeted therapies and immunotherapies, for non-small cell lung cancer. A high-level overview of Genprex, Inc. Genprex last posted its earnings data on August 11th,.
360 USD at. stock news by MarketWatch. The Genprex stock forecast is 2. The average price target represents a 48. stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock. · The GNPX stock price is -85% off its 52-week high price of .
Common Stock (GNPX) at Nasdaq. Analysts have given the company’s stock an average 52-week price target of , forecast between a low of and high of . · GNPX | Complete Genprex Inc.
The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates. · According to Zacks Investment Research, based on 1 analysts’ forecasts, the consensus EPS forecast for the quarter is $-0. Genprex (NASDAQ:GNPX) Earnings Information Genprex last posted its quarterly earnings data on August 11th,. View which stocks have been most impacted by COVID-19. · View GENPREX INC GNPX investment & stock information. 3%) rallies on a healthy 45x surge in volume in reaction to Fast Track status in the U. What this means: Genprex Inc (GNPX) gets a very positive evaluation from InvestorsObserver&39;s ranking system.
(GNPX) stock quote, history, news and other vital information to help you with your stock trading and investing. This price target is based on 2 analysts offering 12 month price targets for Genprex in the last 3 months. 19% in the 30-day chart. From the Web; Energy Transfer LP (ET) Gains But Lags Market: What You Should Know From Zacks Investment Research. 00 shows a potential of 134. 67) earnings per share over the last year. Signals & Forecast. See the latest EPS estimates.
View real-time stock prices and stock quotes for a full financial overview. stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. Genprex Stock Forecast is based on your current time horizon. In the short term (2weeks), GNPX&39;s stock price should outperform the market by 5.
Genprex Inc quote is equal to 3. Find real-time GNPX - Genprex Inc stock quotes, company profile, news and forecasts from CNN Business. Stock Price Forecast, "GNPX" Predictons for. We’re passionate about the work we’re doing to fight cancer and diabetes, and we want to keep our current and potential investors informed on our day-to-day advancements. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. (GNPX) has a beta value of 0, and an average true range (ATR) of 0. GNPX Stock Analysis Overview.
37% upside from the last price of . Further, Genprex, Inc. 00 and a low forecast of . Genprex Inc dominated the market today, gaining €0. Based on our forecasts, a long-term increase is expected, the "GNPX" stock price prognosis foris 15. 8% and is now trading at . 42 on March 11th, when Coronavirus reached pandemic status according to the World Health Organization. · Genprex Inc.
The reported EPS for the same quarter last year was $-0. 899% for Genprex Inc which would more than double the current price.
-> Dvn stock news
-> Electricity stocks to buy